Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs

1996 ◽  
Vol 6 (1) ◽  
pp. 61-74 ◽  
Author(s):  
Doina Ganea
1999 ◽  
Vol 84 (10) ◽  
pp. 3739-3744 ◽  
Author(s):  
Martin Willheim ◽  
Ralf Thien ◽  
Karl Schrattbauer ◽  
Erika Bajna ◽  
Margareta Holub ◽  
...  

2007 ◽  
Vol 182 (1-2) ◽  
pp. 48-54 ◽  
Author(s):  
Yuesong Weng ◽  
Juyun Sun ◽  
Qianqian Wu ◽  
Jianping Pan

1997 ◽  
Vol 72 (1) ◽  
pp. 41-54 ◽  
Author(s):  
Zhicheng Xin ◽  
Xiaoming Jiang ◽  
Hong-Ying Wang ◽  
Thomas N Denny ◽  
Bonnie N Dittel ◽  
...  

1992 ◽  
Vol 1 (1) ◽  
pp. 5-8 ◽  
Author(s):  
M. Rola-Pleszczynski ◽  
J. Stankova

The initial response of the host to noxious stimuli produces a nonspecific inflammatory response. A more specific immune response is believed to be modulated by two classes of molecules: lipid mediators (PG, LT and PAF) and cytokines, synthesized by phagocytes and parenchyreal cells. In this review we discuss the increasing evidence of the interrelationship between eicosanoids, PAF and cytokines: IL-1 and TNF induce PG synthesis in various cells and PG, in turn, modulate cytokine production. We focused on the regulatory effects ofLTB4,PGE2and PAF on cytokine gene expression.


1999 ◽  
Vol 84 (1-3) ◽  
pp. 55-67 ◽  
Author(s):  
Hong-Ying Wang ◽  
Xiaoming Jiang ◽  
Illana Gozes ◽  
Mati Fridkin ◽  
Douglas E Brenneman ◽  
...  

Blood ◽  
2000 ◽  
Vol 95 (6) ◽  
pp. 2031-2036 ◽  
Author(s):  
Paola Sacerdote ◽  
Barbara Manfredi ◽  
Leda Gaspani ◽  
Alberto E. Panerai

Abstract Opioid peptides affect different immune functions. We present evidence that these effects could be mediated by the modulation of TH1/TH2 cytokine production. BALB/cJ mice were immunized with 50 or 100 μg of the protein antigen keyhole-limpet hemocyanin (KLH), and treated acutely or chronically with the opioid antagonist naloxone. One and 2 weeks after immunization, the production of cytokines by splenocytes was evaluated by in vitro restimulation with KLH. The acute and chronic treatment with the opioid receptor antagonist naloxone decreased the production of interleukin (IL)–4 by splenocytes of BALB/cJ mice. In contrast, IL-2 and interferon-γ levels increased after naloxone treatment. Finally, the opioid antagonist diminished the serum immunoglobulin G anti–KLH antibody titers. These results suggest that naloxone increases TH1 and decreases TH2 cytokine production. The effect of naloxone could be ascribed to the removal of the regulatory effects exerted by endogenous opioid peptides, which could therefore activate TH2 and suppress TH1 cytokines.


Sign in / Sign up

Export Citation Format

Share Document